Key result
Pacemaker implantation in dogs is linked to reduced myocardial impedance and ~30 months median survival.
Why the study?
How do cardiac pacemaker parameters behave over time in dogs?
Cohort (n=11)
No
How do cardiac pacemaker parameters behave over time in dogs?
In dogs receiving cardiac pacemakers, myocardial impedance significantly decreases over time, suggesting clinical interpretation should focus on longitudinal changes relative to baseline rather than isolated reference ranges.
Answers are grounded in this paper and cite their sources.
Clinicians should track serial impedance changes from baseline in dogs with pacemakers; this Level 3 evidence leaves open links to outcomes or management.
Objective: To report the behavior of the main parameters used in the evaluation of cardiac pacemakers (PMs) in dogs, associated complications, and survival times. Methods: This retrospective cohort study evaluated dogs that received PMs (from 2016 through 2023) at a veterinary teaching hospital. Dogs of various breeds, ages, and sexes with at least 1 baseline assessment were included. The PM parameters pacing threshold amplitude, impedance (or conductance), and estimated battery life were assessed immediately after PM insertion and at reevaluation times (≤ 7, ≤ 90, ≤ 547, ≤ 912, and ≥ 912 days). Complications and survival rates were also evaluated. Results: The median survival time of 11 dogs was 30 months. Two complications were recorded: seroma and suture dehiscence. A reduction in impedance over time was further validated by a significant Skillings-Mack test (χ2 = 12.692; P = .0054). Pacing threshold amplitude and estimated battery life did not significantly change. Conclusions: PM implantation in dogs is safe and eliminates clinical signs. A reduction in myocardial impedance (or increased conductance) is expected, but impedance assessment should consider individual baselines, observing the behavior rather than just the normal range or isolated values. Baseline pacing threshold amplitude also varies between individuals and tends to decrease over time. No significant reduction in estimated battery life was observed during the study period, probably due to high device longevity. Clinical Relevance: This study provides the first data for PM parameters in dogs. The results suggest that clinical interpretation should focus on longitudinal parameter behavior relative to baseline values rather than solely on the reference range.
No takes yet. Share an insight, caveat, or question.
Oyafuso et al. (2026) conducted a cohort in Cardiac pacemakers in dogs (n=11). Cardiac pacemakers was evaluated on Impedance over time (p=0.0054). Cardiac pacemaker implantation in dogs was associated with a significant reduction in myocardial impedance over time, with a median survival time of 30 months.
Synapse has enriched 10 related papers. Consider them for comparative context: